Information  X 
Enter a valid email address

Antisoma plc (SRC)

  Print      Mail a friend       Annual reports

Thursday 13 November, 2008

Antisoma plc

Share Dealing





London, UK, and Cambridge, MA: 13 November 2008 - Cancer drug
developer Antisoma plc  (LSE: ASM; USOTC: ATSMY) has received
notification that its Chief Financial Officer, Eric Dodd, has
purchased 1p ordinary Antisoma shares as follows:



+--------------------------------------------------------------------+
|CFO   |Date of      |Amount     |Price  |Total  amount|% of Company |
|      |transaction  |of shares  |(p)    |of           |held         |
|      |             |purchased  |       |shares   held|following the|
|      |             |           |       |in the       |transaction  |
|      |             |           |       |Company      |             |
|      |             |           |       |following    |             |
|      |             |           |       |the          |             |
|      |             |           |       |transaction  |             |
|------+-------------+-----------+-------+-------------+-------------|
|Eric  |11.11.2008   |50,000     |20.5   |50,000       |0.008%       |
|Dodd  |             |           |       |             |             |
|      |             |           |       |             |             |
+--------------------------------------------------------------------+



Enquiries:
Daniel Elger,
Director of Communications, Antisoma plc
+44 (0) 20 3249 2100

---END OF MESSAGE---




This announcement was originally distributed by Hugin. The issuer is 
solely responsible for the content of this announcement.